Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
2.400
0.00 (0.00%)
Apr 16, 2026, 10:58 AM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $343.86 million as of April 16, 2026. Its market cap has increased by 158.21% in one year.
Market Cap
343.86M
Enterprise Value
258.91M
Revenue
559.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.40
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 343.86M, a decrease of -36.13%. That is a compound annual growth rate of -7.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 343.86M | 19.74% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 454.75M |
| Northwest Biotherapeutics | 323.97M |
| Vaxart | 168.57M |
| HST Global | 88.40M |
| BioStem Technologies | 82.00M |
| Nuo Therapeutics | 69.54M |
| Cell Source | 58.44M |
| Vicapsys Life Sciences | 47.26M |